Page last updated: 2024-11-05

dibutylamine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID8148
CHEMBL ID3184528
SCHEMBL ID2532
MeSH IDM0131748

Synonyms (59)

Synonym
111-92-2
dibutylamine
dibutyl-amine
n-butylbutan-1-amine
1-butanamine, n-butyl-
inchi=1/c8h19n/c1-3-5-7-9-8-6-4-2/h9h,3-8h2,1-2h
di-(n-butyl)amine
n-butyl-1-butanamine
einecs 203-921-8
ai3-15329
brn 0506001
un2248
dibutilamina [romanian]
n-dibutylamine
hsdb 310
ai3-52649
dibutylamine, >=99.5%
dibutylamine, >=98%
di-n-butylamine
STK380649
D0218
AKOS000118844
dibutilamina
NCGC00248600-01
BBL002913
cas-111-92-2
tox21_200418
dtxsid7024952 ,
dtxcid504952
NCGC00257972-01
2194m2la21 ,
unii-2194m2la21
ec 203-921-8
di-n-butylamine [un2248] [corrosive]
FT-0625169
n-dibutylamine [mi]
SCHEMBL2532
di-1-butylamine
di-n-butyl amine
di(n-butyl)amine
di-normal-butylamine
n,n-di-n-butylamine
n,n-dibutylamine
dibutyl amine
(n-c4h9)2nh
n,n-dibutylamine #
un 2248
W-108664
CHEMBL3184528
F2190-0305
mfcd00009429
dibutylamine, saj first grade, >=98.0%
dibutylamine, puriss., >=99.0% (gc)
dibutylamine, 99%
Z102766286
Q1209336
AMY21922
STR01268
EN300-18950

Research Excerpts

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (1)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency54.26110.003041.611522,387.1992AID1159552; AID1159555
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (28)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (14.29)18.7374
1990's4 (14.29)18.2507
2000's10 (35.71)29.6817
2010's9 (32.14)24.3611
2020's1 (3.57)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 45.86

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index45.86 (24.57)
Research Supply Index3.43 (2.92)
Research Growth Index4.70 (4.65)
Search Engine Demand Index67.44 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (45.86)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other30 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]